Predictive value of plasma copeptin level for diagnosis and mortality of pulmonary embolism.

Creative Commons License

Ozmen C., Deveci O. S., Karaaslan M. B., Baydar O., Akray A., Deniz A., ...Daha Fazla

Revista da Associacao Medica Brasileira (1992), cilt.66, sa.12, ss.1645-1650, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 66 Sayı: 12
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1590/1806-9282.66.12.1645
  • Dergi Adı: Revista da Associacao Medica Brasileira (1992)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.1645-1650
  • Anahtar Kelimeler: Biomarkers, Death, Pulmonary embolism/diagnosis, Pulmonary embolism/mortality, Arginine vasopressin/metabolism, RISK STRATIFICATION, ARGININE-VASOPRESSIN, STABLE PEPTIDE, PATHOPHYSIOLOGY, QUANTIFICATION, PRECURSOR, IMPACT
  • Çukurova Üniversitesi Adresli: Evet

Özet

OBJECTIVE: Early diagnosis and risk stratification may provide a better prognosis in pulmonary embolism (PE). Copeptin has emerged as a valuable predictive biomarker in various cardiovascular diseases. The aim of this study was to determine the levels of copeptin in patients with acute PE and to evaluate its relationship with disease severity and PE-related death.